The enigma of CD57+ CD28- T cell expansion - Anergy or activation?

Clinical and Experimental Immunology

Volumn 104, Issue 1, 1996, Pages 180-184

  Kern, F ^a   Ode Hakim, S ^a   Vogt, K ^a   Hoflich C ^a   Reinke, P ^a   Volk, H D ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

CD28 antigen; CD57 antigen; cytomegalovirus infection; immune activation

Indexed keywords

CD28 ANTIGEN; CD57 ANTIGEN; CYTOKINE; FAS ANTIGEN;

ANERGY; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ETIOLOGY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOCYTE ACTIVATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029930578     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-635.x     Document Type: Article

References (13)

1. Borthwick NJ, Bofill M, Gombert WM et al. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28 T cells. AIDS 1994; 8:431-41.
2. +) lymphocytes in relation to cytomegalovirus carrier status. Clin Exp immunol 1988; 74:190-5.
3. + T cells. Clin Exp Immunol 1994; 95:465-71.
4. + T cells from HIV-infected persons. J immunol 1994; 153:412-20.
5. + lymphocytes in kidney-transplanted patients. Phenotypic and functional study. Presse Med 1992; 21:1985-6.
6. + cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin Exp Immunol 1993; 94:297-305.
7. Harlan DM, Abe R, Lee KP, June CH. Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion. Clin Immunol Immunopathol 1995; 75:99-111.
8. Azuma M, Phillips JH, Lanier LL. CD28 T lymphocytes. J immunol 1993; 150:1147-59.
9. Kern F, Döcke WD, Reinke P, Volk HD. Discordant expression of LFA-1, VLA-beta1, CD45RO and CD28 on Tcell subsets: evidence for multiple subsets of 'memory' T cells. Int Arch Allergy Immunol 1994; 104:17-26.
10. +/LFA-1 'bright' T cells represent memory-type effector cells, which, during immune activation in kidney graft recipients, are marked by increased cytokine mRNA levels. Transplant Proc 1995; 27:896-9.
11. Platzer C, Ode-Hakim S, Reinke P, Döcke WD, Ewert R, Volk HD. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 1994; 58:264-8.
12. Platzer C, Richter G, Überla K, Müller W, Blocker H, Diamantstein T, Blankenstein T. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur J Immunol 1992; 22:1179-84.
13. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993; 362:758-61.